Equity Investor Presentation December 31, 2025 Forward-Looking Statements and Safe Harbor Disclosure 2 ASSURED GUARANTY LTD. • This presentation contains information that includes or is based upon forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward looking statements give the expectations or forecasts of future events of Assured Guaranty Ltd. (AGL) and its subsidiaries (collectively with AGL, Assured Guaranty or the Company). These statements can be ...

Supplemental Information Fourth Quarter 2025 Disclaimers IN GENERAL . Thisdisclaimerapplies tothisdocumentand theverbal or writtencommentsof any personpresentingit. Thisdocument,takentogetherwithany suchverbal or writtencomments,is referredtohereinas the "Presentation." Theinformationcontainedon, or accessible through,any websitesincludedin thisPresentationis notincorporatedby referenceinto,and shouldnotbe considereda partof, thisPresentation. FORWARD -LOOKING STATEMENTS . Certainstatementsin thisPresentati ...

Bain Capital Specialty Finance, Inc. Fourth Quarter Ended December 31, 2025 Earnings Presentation DISCLAIMER PLEASE CONSIDER THE FOLLOWING In this material Bain Capital Credit, LP, Bain Capital Credit (Australia), Pty. Ltd., Bain Capital Credit, Ltd., Bain Capital Investments (Europe) Limited, Bain Capital Investments (Ireland) Limited, Bain Capital Credit CLO Advisors, LP, Bain Capital Credit U.S. CLO Manager, LLC, Bain Capital Credit U.S. CLO Manager II, LP, Bain Capital Credit (Asia) Limited, Bain Capita ...

Investor Presentation Q4 2025 Updated February 27, 2026 1 Forward-Looking Statements and Non-GAAP Financial Information This presentation contains statements about 1stdibs.com, Inc.'s (the "Company") future financial results, plans, and efforts to expand our market share that are "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve substantial risks and uncertainties. Any statements cont ...

Acrivon T h e r a p e u t i c s Acrivon T h e r a p e u t i c s KOL PANEL DISCUSSION ACR-368 ENDOMETRIAL C ANCER TRIAL Certain information contained in this presentation and related webcast includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations. In some cases, you can identify forward-looking statements becau ...

RESULTS DISCLAIMER Any statements that may be made during this conference call regarding Copel's business prospects, projections, and operational and financial goals are based on the beliefs and assumptions of the Company's management, as well as on currently available information. Forward-looking statements are not guarantees of performance; they involve risks, uncertainties, and assumptions, as they refer to future events and therefore depend on circumstances that may or may not General economic condition ...

February 27, 2026 4Q and Full-Year 2025 Earnings Results Call © 2026 ANI Pharmaceuticals, Inc. 1 Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that are not historical facts, including statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are forward- l ...

February 2026 Investor Presentation Note: All financials presented are in US$ unless otherwise noted. Disclaimer General This presentation is property of Docebo Inc. (the "Company", "Docebo", "us" or "we"). It cannot be circulated or forwarded without our consent. Any graphs, tables or other information demonstrating our historical performance or that of any other entity contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of our or such entities ...

Brookfield Business Partners Investor Presentation February 2026 Brookfield Business Partners Flagship listed vehicle of Brookfield's private equity group, focused on continuing a long- term track record of compounding strong returns for investors BBU/BBUC NYSE & TSX Listed ~$7B Market Capitalization1,2 Investing alongside Brookfield's private equity strategies, executing a consistent playbook developed and refined over the past 25+ years Focused on owning and operating high-quality, vital industrial and se ...

ENERGY THAT TRANSFORMS INVESTOR PRESENTATION MARCH 2026 Disclaimer Except as expressly noted, the information in this presentation is current as of Feb. 25, 2026, and should not be relied upon as being current as of any subsequent date. Avista undertakes no duty to update this presentation, except as may be required by law. All forward-looking statements in this presentation are based on underlying assumptions (many of which are based, in turn, upon further assumptions). These statements are subject to a va ...